Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 21, 2006
Human Molecular Genetics 2006 15(19):2880-2887; doi:10.1093/hmg/ddl229
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
15/19/2880    most recent
ddl229v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tosh, K.
Right arrow Articles by Pitchappan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosh, K.
Right arrow Articles by Pitchappan, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India

Kerrie Tosh1,{dagger},{ddagger}, Muthuswamy Ravikumar2,{dagger},{ddagger}, Jordana Tzenova Bell1, Sarah Meisner1,{ddagger}, Adrian V.S. Hill1,* and Ramasamy Pitchappan2

1 The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, OX3 7BN, UK and 2 Centre for Excellence in Genomic Sciences, Madurai Kamaraj University, Madurai 625021, India

* To whom correspondence should be addressed. Tel: +44 1865287759; Fax: +44 1865287686; Email: adrian.hill{at}well.ox.ac.uk

Received May 24, 2006; Accepted August 10, 2006

In a study of mainly paucibacillary leprosy-affected sib-pair families from South India, in addition to the expected associations with the HLA-DRB1 locus, we have identified significant association with a functional variant of the MICA gene as well as a microsatellite in the flanking region of the MICB gene. The associations with MICA and MICB cannot be accounted for by linkage disequilibrium with the HLA class II locus indicating a role in genetic susceptibility to leprosy that is independent of HLA-DRB1. Previous studies have shown that MICA and MICB are expressed on the surface of cells in response to infection, where they are recognized by the NKG2D receptor on {gamma}{delta} T cells, CD8+ {alpha}ß T cells and natural killer cells, all of which contribute to defense against mycobacteria. The MICA*5A5.1 allele, associated here with leprosy susceptibility, encodes a protein lacking a cytoplasmic tail providing a possible mechanism for defective immune surveillance against mycobacteria.


{dagger} The authors wish it to be known that, in their opinion, the first two authors should be considered as joint First Authors.

{ddagger} Present Addresses: Kerrie Tosh, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK; Muthuswamy Ravikumar, Department of Pathology, 323A, Health Science Research Facility, 89 Beaumont Avenue, Burlington, Vermont-05405, USA; Sarah Meisner, Bath Royal United Hospital Trust, Combe Park, Bath BA1 3NG, UK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
J. M. Blackwell, S. E. Jamieson, and D. Burgner
HLA and Infectious Diseases
Clin. Microbiol. Rev., April 1, 2009; 22(2): 370 - 385.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.